Lanying Du Lindsley F. Kimball Research Institute New York Blood Center Biography Publications Institution JoVE Articles Lanying Du has not added a biography. If you are Lanying Du and would like to personalize this page please email our Author Liaison for assistance. Publications CL-385319 Inhibits H5N1 Avian Influenza A Virus Infection by Blocking Viral Entry European Journal of Pharmacology. Jun, 2011 | Pubmed ID: 21536025 Complement Inhibition Alleviates Paraquat-induced Acute Lung Injury American Journal of Respiratory Cell and Molecular Biology. Oct, 2011 | Pubmed ID: 21421909 A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-clade Protection Against Divergent H5N1 Viruses PloS One. 2011 | Pubmed ID: 21304591 Roles of the Hemagglutinin of Influenza A Virus in Viral Entry and Development of Antiviral Therapeutics and Vaccines Protein & Cell. Apr, 2010 | Pubmed ID: 21203946 Potent and Persistent Antibody Responses Against the Receptor-binding Domain of SARS-CoV Spike Protein in Recovered Patients Virology Journal. 2010 | Pubmed ID: 21047436 Induction of Protection Against Divergent H5N1 Influenza Viruses Using a Recombinant Fusion Protein Linking Influenza M2e to Onchocerca Volvulus Activation Associated Protein-1 (ASP-1) Adjuvant Vaccine. Oct, 2010 | Pubmed ID: 20732469 Development of a Safe and Convenient Neutralization Assay for Rapid Screening of Influenza HA-specific Neutralizing Monoclonal Antibodies Biochemical and Biophysical Research Communications. Jun, 2010 | Pubmed ID: 20685351 An H5N1 M2e-based Multiple Antigenic Peptide Vaccine Confers Heterosubtypic Protection from Lethal Infection with Pandemic 2009 H1N1 Virus Virology Journal. 2010 | Pubmed ID: 20624292 Development of a Safe and Convenient Neutralization Assay for Rapid Screening of Influenza HA-specific Neutralizing Monoclonal Antibodies Biochemical and Biophysical Research Communications. Jul, 2010 | Pubmed ID: 20617558 A 219-mer CHO-expressing Receptor-binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity Viral Immunology. Apr, 2010 | Pubmed ID: 20374001 An M2e-based Multiple Antigenic Peptide Vaccine Protects Mice from Lethal Challenge with Divergent H5N1 Influenza Viruses Virology Journal. 2010 | Pubmed ID: 20082709 Research and Development of Universal Influenza Vaccines Microbes and Infection / Institut Pasteur. Apr, 2010 | Pubmed ID: 20079871 Recombinant Receptor-binding Domain of SARS-CoV Spike Protein Expressed in Mammalian, Insect and E. Coli Cells Elicits Potent Neutralizing Antibody and Protective Immunity Virology. Oct, 2009 | Pubmed ID: 19683779 Antigenicity and Immunogenicity of SARS-CoV S Protein Receptor-binding Domain Stably Expressed in CHO Cells Biochemical and Biophysical Research Communications. Jul, 2009 | Pubmed ID: 19422787 The Spike Protein of SARS-CoV--a Target for Vaccine and Therapeutic Development Nature Reviews. Microbiology. Mar, 2009 | Pubmed ID: 19198616 Evaluation of Recombinant Onchocerca Volvulus Activation Associated Protein-1 (ASP-1) As a Potent Th1-biased Adjuvant with a Panel of Protein or Peptide-based Antigens and Commercial Inactivated Vaccines Vaccine. Sep, 2008 | Pubmed ID: 18675867 Development of Subunit Vaccines Against Severe Acute Respiratory Syndrome Drugs of Today (Barcelona, Spain : 1998). Jan, 2008 | Pubmed ID: 18301805 Priming with RAAV Encoding RBD of SARS-CoV S Protein and Boosting with RBD-specific Peptides for T Cell Epitopes Elevated Humoral and Cellular Immune Responses Against SARS-CoV Infection Vaccine. Mar, 2008 | Pubmed ID: 18289745 Intranasal Vaccination of Recombinant Adeno-associated Virus Encoding Receptor-binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-term Protection Against SARS-CoV Infection Journal of Immunology (Baltimore, Md. : 1950). Jan, 2008 | Pubmed ID: 18178835 Cleavage of Spike Protein of SARS Coronavirus by Protease Factor Xa is Associated with Viral Infectivity Biochemical and Biophysical Research Communications. Jul, 2007 | Pubmed ID: 17533109 Receptor-binding Domain of SARS-CoV Spike Protein Induces Long-term Protective Immunity in an Animal Model Vaccine. Apr, 2007 | Pubmed ID: 17092615 Severe Acute Respiratory Syndrome-associated Coronavirus 3a Protein Forms an Ion Channel and Modulates Virus Release Proceedings of the National Academy of Sciences of the United States of America. Aug, 2006 | Pubmed ID: 16894145 Recombinant Adeno-associated Virus Expressing the Receptor-binding Domain of Severe Acute Respiratory Syndrome Coronavirus S Protein Elicits Neutralizing Antibodies: Implication for Developing SARS Vaccines Virology. Sep, 2006 | Pubmed ID: 16793110 Identification and Characterization of Novel Neutralizing Epitopes in the Receptor-binding Domain of SARS-CoV Spike Protein: Revealing the Critical Antigenic Determinants in Inactivated SARS-CoV Vaccine Vaccine. Jun, 2006 | Pubmed ID: 16725238 Synthetic Peptides Outside the Spike Protein Heptad Repeat Regions As Potent Inhibitors of SARS-associated Coronavirus Antiviral Therapy. 2005 | Pubmed ID: 15918330 بروتوكول لقاحات مرض السارس المؤتلف RBD المستندة : إعداد البروتين ، والكشف عن تطعيم الحيوانات تحييد Lanying Du1, Xiujuan Zhang1, Jixiang Liu1, Shibo Jiang1 1Lindsley F. Kimball Research Institute, New York Blood Center JoVE 2444 면역학 및 감염병학
بروتوكول لقاحات مرض السارس المؤتلف RBD المستندة : إعداد البروتين ، والكشف عن تطعيم الحيوانات تحييد Lanying Du1, Xiujuan Zhang1, Jixiang Liu1, Shibo Jiang1 1Lindsley F. Kimball Research Institute, New York Blood Center JoVE 2444 면역학 및 감염병학